找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Computer Aided Pharmaceutics and Drug Delivery; An Application Guide Vikas Anand Saharan Book 2022 Springer Nature Singapore Pte Ltd. 2022

[復(fù)制鏈接]
樓主: 和善
21#
發(fā)表于 2025-3-25 05:56:43 | 只看該作者
Ethanolamines and Secondary Products,16, the very first 3D printlet of Levetiracetam (approved by USFDA) was successfully manufactured by Aprecia Pharmaceuticals, Pennsylvania which is used to treat epilepsy. Despite the exciting recent advances in 3D printing, there are still notable scientific and regulatory obstacles. As a result, t
22#
發(fā)表于 2025-3-25 09:15:26 | 只看該作者
Ethylenediamine and Chelating Agents,d to predict the oral absorption of virtual compounds and thus offer the potential to screen the molecules under development that is having a prerequisite absorption profile. The present chapter deals with basics and recent advances along with applications and limitations of commonly used in silico
23#
發(fā)表于 2025-3-25 13:54:00 | 只看該作者
Hexamethylenetetramine (Hexamine),e primary focus is on the establishment of relationship between therapeutic drug concentration and patient response. The aim of this chapter is to discuss the role, advancement, and development of biocomputational tools used in research and development in the pharmaceutical industry, wherein the num
24#
發(fā)表于 2025-3-25 18:14:17 | 只看該作者
25#
發(fā)表于 2025-3-25 22:39:43 | 只看該作者
Ethylenediamine and Chelating Agents,s and databases which are used in clinical development of a drug product. Studies like drug interaction, dose calculations, stability studies, statistical evaluation, clinical trial study evaluation, pharmacovigilance safety extensively rely on use of softwares, databases, and computers. This chapte
26#
發(fā)表于 2025-3-26 02:03:38 | 只看該作者
Janusz Jurczak,Marek Pietraszkiewiczents, and much collaboration among companies like pharmaceuticals, medical devices, life sciences, and AI technology is observed very recently. This chapter focuses on introducing the concepts of AI, algorithms, and their applications in advancing drug discovery, formulation development, therapy, an
27#
發(fā)表于 2025-3-26 07:22:29 | 只看該作者
28#
發(fā)表于 2025-3-26 12:15:42 | 只看該作者
29#
發(fā)表于 2025-3-26 13:50:26 | 只看該作者
Thierry Lepoint,Fran?oise Lepoint-Mullielity, etc.) required in desired molecule that will influence binding affinity and helps in optimization of known ligands for designing and development of new molecules with improved activity and safety profiles. This chapter focuses on the different computational approaches such as molecular docking
30#
發(fā)表于 2025-3-26 19:04:05 | 只看該作者
K. C. Khulbe,C. Y. Feng,Takeshi Matsuura should be followed. Developed QSPR models are beneficial in predicting the biological activities of untested/new molecules, alternative of animal experiments, thus reducing animal use, refinement of synthetic targets, assumption of ADME and toxicity studies, etc. In this chapter, we focus on the va
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 10:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
霍山县| 韶山市| 奎屯市| 田林县| 吐鲁番市| 昆山市| 资阳市| 琼中| 同德县| 司法| 台南市| 施甸县| 延吉市| 秦安县| 宜丰县| 岗巴县| 通辽市| 海丰县| 红河县| 郓城县| 平安县| 商河县| 高州市| 平舆县| 甘泉县| 嘉义市| 海淀区| 维西| 肥乡县| 宁波市| 黄梅县| 大英县| 黑水县| 天峨县| 罗甸县| 嵩明县| 德昌县| 新津县| 文昌市| 铜陵市| 绥芬河市|